CVS CVS HEALTH Corp

Price (delayed)

$69.75

Market cap

$87.78B

P/E Ratio

10.75

Dividend/share

$2.54

EPS

$6.49

Enterprise value

$158.97B

CVS Health is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. ...

Highlights
CVS's price to earnings (P/E) is 43% lower than its last 4 quarters average of 19.0 and 37% lower than its 5-year quarterly average of 17.1
The revenue has grown by 11% YoY and by 2.9% from the previous quarter
CVS HEALTH's EPS has surged by 97% YoY but it has decreased by 2.8% QoQ
The net income has surged by 94% year-on-year but it has declined by 3.3% since the previous quarter
The debt has grown by 12% YoY
CVS's gross margin is down by 10% YoY and by 2.6% QoQ

Key stats

What are the main financial stats of CVS
Market
Shares outstanding
1.26B
Market cap
$87.78B
Enterprise value
$158.97B
Valuations
Price to book (P/B)
1.17
Price to sales (P/S)
0.25
EV/EBIT
11.51
EV/EBITDA
11.51
EV/Sales
0.44
Earnings
Revenue
$357.78B
EBIT
$13.81B
EBITDA
$13.81B
Free cash flow
$10.4B
Per share
EPS
$6.49
Free cash flow per share
$8.09
Book value per share
$59.42
Revenue per share
$278.42
TBVPS
$100.56
Balance sheet
Total assets
$249.73B
Total liabilities
$173.09B
Debt
$79.39B
Equity
$76.46B
Working capital
-$11.33B
Liquidity
Debt to equity
1.04
Current ratio
0.86
Quick ratio
0.59
Net debt/EBITDA
5.16
Margins
EBITDA margin
3.9%
Gross margin
15.2%
Net margin
2.3%
Operating margin
3.8%
Efficiency
Return on assets
3.4%
Return on equity
11.3%
Return on invested capital
11.7%
Return on capital employed
8.1%
Return on sales
3.9%
Dividend
Dividend yield
3.64%
DPS
$2.54
Payout ratio
39.1%

CVS stock price

How has the CVS HEALTH stock price performed over time
Intraday
0.52%
1 week
1.62%
1 month
-10.65%
1 year
-6.01%
YTD
-11.66%
QTD
-12.55%

Financial performance

How have CVS HEALTH's revenue and profit performed over time
Revenue
$357.78B
Gross profit
$54.43B
Operating income
$13.74B
Net income
$8.34B
Gross margin
15.2%
Net margin
2.3%
The net income has surged by 94% year-on-year but it has declined by 3.3% since the previous quarter
The net margin has soared by 77% YoY but it has contracted by 8% from the previous quarter
The operating income has surged by 73% year-on-year but it has declined by 2% since the previous quarter
The company's operating margin has surged by 52% YoY but it fell by 5% QoQ

Growth

What is CVS HEALTH's growth rate over time

Valuation

What is CVS HEALTH stock price valuation
P/E
10.75
P/B
1.17
P/S
0.25
EV/EBIT
11.51
EV/EBITDA
11.51
EV/Sales
0.44
CVS HEALTH's EPS has surged by 97% YoY but it has decreased by 2.8% QoQ
CVS's price to earnings (P/E) is 43% lower than its last 4 quarters average of 19.0 and 37% lower than its 5-year quarterly average of 17.1
CVS's price to book (P/B) is 16% less than its 5-year quarterly average of 1.4 and 10% less than its last 4 quarters average of 1.3
CVS's equity is up by 7% YoY and by 2.9% QoQ
The stock's price to sales (P/S) is 17% less than its 5-year quarterly average of 0.3 and 17% less than its last 4 quarters average of 0.3
The revenue has grown by 11% YoY and by 2.9% from the previous quarter

Efficiency

How efficient is CVS HEALTH business performance
CVS's ROE has soared by 92% YoY but it is down by 5% QoQ
The return on assets has surged by 79% year-on-year but it has declined by 6% since the previous quarter
CVS HEALTH's return on invested capital has surged by 67% YoY but it has decreased by 4.1% QoQ
CVS HEALTH's return on sales has surged by 56% YoY but it has decreased by 4.9% QoQ

Dividends

What is CVS's dividend history
DPS
$2.54
Dividend yield
3.64%
Payout ratio
39.1%
Recent dividends

Financial health

How did CVS HEALTH financials performed over time
CVS HEALTH's total assets is 44% more than its total liabilities
The company's total liabilities rose by 11% YoY but it fell by 2.1% QoQ
The current ratio has declined by 9% year-on-year
The debt is 3.8% more than the equity
The debt has grown by 12% YoY
CVS's equity is up by 7% YoY and by 2.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.